Zynerba Pharmaceuticals, Inc.
TREATMENT OF FRAGILE X SYNDROME WITH CANNABIDIOL

Abstract:

The present technology relates to a method of treating one or more symptoms of Full Methylation (Fmet) Fragile X Syndrome in a subject that includes administering an effective amount of cannabidiol to the subject such that one or more symptoms of Fragile X Syndrome are treated.